Preventing and Managing Resistance in the Clinical Setting

This publication has 10 references indexed in Scilit:

• Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel
  Clinical Infectious Diseases, 2003
• Improving lopinavir genotype algorithm through phenotype correlations
  AIDS, 2003
• Methods for Integration of Pharmacokinetic and Phenotypic Information in the Treatment of Infection with Human Immunodeficiency Virus
  Clinical Infectious Diseases, 2003
• A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women
  AIDS, 2002
• Position Paper on Therapeutic Drug Monitoring of Antiretroviral Agents
  AIDS Research and Human Retroviruses, 2002
• Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
  New England Journal of Medicine, 2002
• Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
  AIDS, 2001
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
  Annals of Internal Medicine, 2000
• Drug Susceptibility in HIV Infection After Viral Rebound in Patients Receiving Indinavir-Containing Regimens
  JAMA, 2000
• Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of In Vitro Lamivudine Drug Pressure
  Antiviral Therapy, 1998